col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


301 Results       Page 1

 [1] 
Elsevier: International Immunopharmacology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―16 A pilot randomized controlled trial of major ozone autohemotherapy for patients with post-acute sequelae of COVID-19 Yang He, Xu Liu, Shiqian Zha, Yixuan Wang, Jingyi Zhang, Qingfeng Zhang, Ke Hu
2 [GO] 2024―Jul―14 Expression of concern: “Different T cell related immunological profiles in COVID-19 patients compared to healthy controls” [Int. Immunopharmacol. 97 (2021) 107828] Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, Lis M. Yapanto, Mohsen Nabi Afjadi, et al. (+12)
3 [GO] 2024―Jun―11 Immune checkpoint inhibitors and SARS-CoV2 infection Samaneh Abdolmohammadi-Vahid, Behzad Baradaran, Ian M. Adcock, Esmaeil Mortaz
4 [GO] 2024―May―25 Treatment with immunosuppressants did not increase the risk of COVID-19 in pemphigus patients: A single-center survey-based study Xun Feng, Xingli Zhou, Xiwen Zhang, Yue Xiao, Furong Li, Wenyao Mi, et al. (+6)
5 [GO] 2024―May―20 SARS-CoV-2 infection, vaccination and in vitro fertilization treatment: A prospective cohort study Xudong Zhang, Xinyao Li, Wanmeng Chen, Shanshan Wu, Xiaohan Qi, Jiansu Bian, et al. (+3)
6 [GO] 2024―May―17 Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up Mohammadreza Salehi, Ilad Alavi Darazam, Alireza Nematollahi, Masoumeh Alimohammadi, Sedigheh Pouya, Reza Alimohammadi, et al. (+9)
7 [GO] 2024―May―11 A prospective cohort-based artificial intelligence evaluation system for the protective efficacy and immune response of SARS-CoV-2 inactivated vaccines Jin Zhang, Yuan Meng, Mei Yang, Wudi Hao, Jianhua Liu, Lina Wu, et al. (+10)
8 [GO] 2024―Apr―14 Duration of antibody response to the receptor binding domain of SARS-CoV-2 in infected or vaccinated individuals - A one year retrospective cohort study Martin Pasev, Angelina Trifonova, Andrey Velichkov, Velislava Terzieva
9 [GO] 2024―Apr―13 Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study Congqin Chen, Chunmei Chen, Longxing Cao, Jie Fang, Jie Xiao
10 [GO] 2024―Apr―13 Serum Dehydroepiandrosterone sulfate (DHEA-S) level and its potential impact on immune responses and symptom severity after Oxford-AstraZeneca COVID-19 vaccination Mitra Abbasifard, Maryam Dehghan Banadaki, Gholamhossein Taghipour Khaje Sharifi, Amir Rahnama, Zahra Bagheri-Hosseinabadi
11 [GO] 2024―Apr―11 Impact of COVID-19 on arthritis with generative AI Yoshiyasu Takefuji
12 [GO] 2024―Mar―29 Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine: From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist Xiongyan Meng, Ying Xu, Jing Yang, Shuai Meng, Ning Ding, Tiantian Sun, Chengli Zong
13 [GO] 2024―Mar―27 Current landscape of long COVID clinical trials Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, Shyam Sundar Nandi, Sang-Soo Lee, Chiranjib Chakraborty
14 [GO] 2024―Mar―14 A prognostic model for SARS-CoV-2 breakthrough infection: Analyzing a prospective cellular immunity cohort Mei Yang, Yuan Meng, Wudi Hao, Jin Zhang, Jianhua Liu, Lina Wu, et al. (+13)
15 [GO] 2024―Mar―05 Endothelial dysfunction and disease severity in COVID-19: Insights from circulating Tang cell counts as a potential biomarker Xiaofeng Liu, Lin Hua, Jinshen Chu, Wei Zhou, Fangtinghui Jiang, Lu Wang, et al. (+4)
16 [GO] 2024―Feb―09 Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice Eun Kim, Juyeop Shin, Alessandro Ferrari, Shaohua Huang, Eunjin An, Donghoon Han, et al. (+6)
17 [GO] 2024―Feb―07 Autoantibody profiles assessment in individuals with persistent olfactory impairment following SARS-CoV-2 infection Denise Fiorelli, Beatrice Francavilla, Gianluca Velletrani, Sara Maurantonio, Francesco Maria Passali, Sergio Bernardini, et al. (+2)
18 [GO] 2024―Feb―06 Association of soluble PD-L1 and NLR combination with 1-Year mortality in patients with COVID-19 Lyudmila Akhmaltdinova, Irina Mekhantseva, Lyudmila Turgunova, Mikhail Kostinov, Zhibek Zhumadilova, Anar Turmukhambetova
19 [GO] 2024―Feb―06 Ferritin-binding and ubiquitination-modified mRNA vaccines induce potent immune responses and protective efficacy against SARS-CoV-2 Tong Yu, ChenChao Zhang, JunHong Xing, Tong Zhang, ZhiQiang Xu, YaXin Di, et al. (+6)
20 [GO] 2024―Feb―03 Combination therapy of high-dose intravenous anakinra and baricitinib in patients with critical COVID-19: Promising results from retrospective observational study Murat Bektaş, Mustafa Ay, Muhammed Hamdi Uyar, Muhammed İkbal Kılıç
21 [GO] 2024―Jan―18 The effects of Annual SZ drug on dynamic changes in lymphocytes and cytokines of COVID-19 patients: A randomized clinical trial Ehsan Soltaninejad, Zuhair Mohammad Hassan, Mir Saeed Yekaninejad, Mehdi Hassaniazad, Elham Barahimi, Afshin Samiei, Masoumeh Ebtekar
22 [GO] 2023―Dec―25 Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial Payam Tabarsi, Setareh Mamishi, Nassim Anjidani, Ramin Shahpari, Hamidreza Kafi, Newsha Fallah, et al. (+8)
23 [GO] 2023―Nov―24 Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds Mohamed E. Elnosary, Mohamed Attia Shreadah, Mohamed L. Ashour, Asmaa Nabil-Adam
24 [GO] 2023―Nov―09 MTOR gene variants are associated with severe COVID-19 outcomes: A multicenter study Bruna Ramos Tosta, Ingrid Marins de Almeida, Laiane da Cruz Pena, Hatilla dos Santos Silva, Fabiane S. Reis-Goes, Nívia N. Silva, et al. (+18)
25 [GO] 2023―Oct―05 Monocytes subpopulations pattern in the acute respiratory syndrome coronavirus 2 virus infection and after long COVID-19 Vanessa Ingrid Cardoso Pereira, Lacy Cardoso de Brito Junior, Luiz Fabio Magno Falcão, Pedro Fernando da Costa Vasconcelos, Juarez Antônio Simões Quaresma, Ana Virgínia Van Dem Berg, et al. (+3)
26 [GO] 2023―Oct―05 Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 Hector Bonilla, Lu Tian, Vincent C. Marconi, Robert Shafer, Grace A. McComsey, Mitchel Miglis, et al. (+4)
27 [GO] 2023―Sep―26 Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing Han Bai, Liyuan Liang, Xin Qi, Yao Xu, Yijia Liu, Doudou Ren, et al. (+6)
28 [GO] 2023―Sep―12 Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI Dominik Felkle, Katarzyna Zięba, Konrad Kaleta, Julia Czaja, Amanda Zyzdorf, Wiktoria Sobocińska, et al. (+3)
29 [GO] 2023―Sep―07 Stem cell-based therapy for COVID-19 Xiaomei Chen, Bowen Liu, Chao Li, Yulian Wang, Suxia Geng, Xin Du, et al. (+2)
30 [GO] 2023―Sep―01 Corrigendum to “The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease” [Int. Immunopharmacol. 98 (2021) 107838] Mehmet Tahir Huyut, Fatih İlkbahar
31 [GO] 2023―Aug―26 Mitochondrial mass of circulating NK cells as a novel biomarker in severe SARS-CoV-2 infection Bingqi Wang, Zhenni Chen, Yiran Huang, Jiayi Ding, Yingrui Lin, Min Wang, Xianping Li
32 [GO] 2023―Aug―24 Differences in leucocytes and inflammation-based indices among critically ill patients owing to SARS-CoV-2 variants during several successive waves of COVID-19 pandemic Awatef Ben Jemaa, Ridha Oueslati, Jihene Guissouma, Hatem Ghadhoune, Hana Ben Ali, Hend Allouche, et al. (+3)
33 [GO] 2023―Aug―24 Azvudine and mortality in patients with coronavirus disease 2019: A retrospective cohort study Bin Liu, Mingjin Yang, Li Xu, Yishi Li, Jing Cai, Bo Xie, et al. (+2)
34 [GO] 2023―Aug―24 Evaluation of T-cell subsets in pregnant women infected with SARS-CoV-2 M. Kulhan, H. Ozdemir, A. Bilgi, C. Celik, N. Aktug Demir, H. Turk Dagi, et al. (+3)
35 [GO] 2023―Aug―23 Corrigendum to “What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?” [Int. Immunopharmacol. 105 (2022) 108542] Mehmet Tahir Huyut, Zübeyir Huyut, Fatih Ilkbahar, Cuma Mertoğlu
36 [GO] 2023―Aug―08 Increased inflammatory mediators levels are associated with clinical outcomes and prolonged illness in severe COVID-19 patients Wendong Hao, Meimei Liu, Cairong Bai, Xin Liu, Siqian Niu, Xiushan Chen
37 [GO] 2023―Jul―25 Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19 Mahsa Khoramipour, Amir Jalali, Bahareh Abbasi, Mohammad Hadi Abbasian
38 [GO] 2023―Jul―15 Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones Riham Abdel-Hamid Haroun, Waleed H. Osman, Rasha E. Amin, Asmaa M. Eessa, Soha Saad
39 [GO] 2023―Jul―13 Serum il-18 and rs187238 single nucleotide polymorphism are associated with high-density lipoprotein changes in covid-19 outpatients Glautemberg de Almeida Viana, Mac Dionys Rodrigues da Costa, Mateus Edson da Silva, Bruna Ribeiro Duque, Erlânia Alves de Siqueira, Alice Maria Costa Martins, et al. (+4)
40 [GO] 2023―Jul―11 Effect of COVID-19 inactivated vaccine on peripheral blood anti-β2-GPI antibody and outcomes in vitro fertilization-embryo transplantation Huiling Zhou, Yilu Zou, Yujia Guo, Xiaoting Lv, Jiajing Chen, Xinxin Guo, Qicai Liu
41 [GO] 2023―Jul―05 Exploring Dysregulated Immune Response Genes and Endothelial Dysfunction Biomarkers as Predictors of Severe COVID-19 Fabiane S. Reis-Goes, Nívia N. Silva, Taiane M. Gondim, Ricardo G. Figueiredo, Gabriella de A. O. Evangelista, Silvana B. Marchioro, et al. (+5)
42 [GO] 2023―Jul―03 Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19 Denise Fiorelli, Vincenza Caruso, Riccardo Belardi, Sergio Bernardini, Marzia Nuccetelli
43 [GO] 2023―Jun―30 Effect of Tofacitinib on Clinical and laboratory findings in Severe and resistant patients with COVID-19 Simin Almasi, Azadeh Rashidi, Manizhe Ataee Kachuee, Bentolhoda Mohammad Shirazi, Shirin Izadi, Sara Ghaffarpour, et al. (+7)
44 [GO] 2023―Jun―16 Reconsideration of interferon treatment for viral diseases: lessons from SARS, MERS, and COVID-19 Dan Ma, Ximin Wang, Min Li, Chujiao Hu, Lei Tang
45 [GO] 2023―Jun―08 COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications Mohammad T. Imam, Ziyad S. Almalki, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Alaa H. Falemban, Ibrahim M. Alanazi, et al. (+4)
46 [GO] 2023―May―22 Comorbid asthma decreased the risk for COVID-19 mortality in the United Kingdom: Evidence based on a meta-analysis Liqin Shi, Yadong Wang, Xueya Han, Ying Wang, Jie Xu, Haiyan Yang
47 [GO] 2023―May―15 Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China Shasha Li, Xiaoqiong Duan, Ning Jiang, Andre J. Jeyarajan, Charlotte A. Warner, Yujia Li, et al. (+10)
48 [GO] 2023―Apr―24 Impact of the MCP-1-2518A>G polymorphism on COVID-19 severity in the Iranian population: A case-control study Niki Ghambari Mohammadi, Saeed Namaki, Seyed Mahmoud Hashemi, Mohammadreza Salehi, Sara Ghaffarpour, Tooba Ghazanfari
49 [GO] 2023―Apr―05 Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents Yufen Zheng, Juan Pan, Minya Jin, Jing Wang, Tao-Hsin Tung, Shiyong Chen, et al. (+7)
50 [GO] 2023―Mar―31 Association of Programmed Cell Death 1 (PD-1) Gene Polymorphism (rs10204525) With COVID-19 Severity and Mortality: A Case-Control Study in the Iranian Population Ensie Sadat Mirsharif, Abdolrahman Rostamian, Mohammadreza Salehi, Nayere Askari, Tooba Ghazanfari
51 [GO] 2023―Mar―29 Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines Mahmoud Kandeel, Mohamed A. Morsy, Hany M. Abd El-Lateef, Mohamed Marzok, Hossam S. El-Beltagi, Khalid M. Al Khodair, et al. (+2)
52 [GO] 2023―Mar―22 Thymosin Alpha 1 Restores the Immune Homeostasis in lymphocytes during Post-Acute Sequelae of SARS-CoV-2 infection Antonella Minutolo, Vita Petrone, Marialaura Fanelli, Christian Maracchioni, Martina Giudice, Elisabetta Teti, et al. (+13)
53 [GO] 2023―Mar―21 Highly pathogenic porcine reproductive and respiratory syndrome virus-induced inflammatory response in porcine pulmonary microvascular endothelial cells and effects of herbal ingredients on main inflammatory molecules Yanmei Wu, Xiaoxiao Song, Peishan Li, Zhaoli Wang, Zhanzhong Zhao, Tao Zhang
54 [GO] 2023―Mar―13 Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model Daniela Ricci, Marilena Paola Etna, Martina Severa, Stefano Fiore, Fabiana Rizzo, Marco Iannetta, et al. (+5)
55 [GO] 2023―Mar―02 COVID-19 and beyond: reassessing the role of thymosin alpha1 in lung infections Marina M. Bellet, Giorgia Renga, Marilena Pariano, Claudia Stincardini, Fiorella D'Onofrio, Allan L. Goldstein, et al. (+3)
56 [GO] 2023―Mar―02 A PILOT TRIAL OF THYMALFASIN (TA1) TO PREVENT COVID-19 INFECTION AND MORBIDITIES IN RENAL DIALYSIS PATIENTS: PRELIMINARY REPORT Cynthia W. Tuthill, Ahmed Awad, Mary Parrigon, William B. Ershler
57 [GO] 2023―Mar―02 Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2 Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, Soliman Mohammadi-Samani
58 [GO] 2023―Feb―27 An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, Behnaz Bakhshandeh, Ramezan Ali Taheri, Hoorieh Soleimanjahi, Reza Zolfaghari Emameh
59 [GO] 2023―Feb―27 SARS-CoV-2 immune complex triggers human monocyte necroptosis Leonardo Duarte Santos, Krist Helen Antunes, Gisele Cassão, João Ismael Gonçalves, Bruno Lopes Abbadi, Cristiano Valim Bizarro, et al. (+4)
60 [GO] 2023―Feb―23 Dual mechanism: epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation Li Fu, Dean Gilham, Stephanie C. Stotz, Christopher D. Sarsons, Brooke D. Rakai, Laura M. Tsujikawa, et al. (+5)
61 [GO] 2023―Feb―07 Effect of Thymalfasin (Thymosin-α-1) on Reversing Lymphocytopenia among Patients with COVID-19 Gregorio Benitez, Fadi Shehadeh, Evangelia K. Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, et al. (+2)
62 [GO] 2023―Jan―24 Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe? Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai
63 [GO] 2023―Jan―11 Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: a reverse vaccinology analysis Fan Jiang, Yinping Liu, Yong Xue, Peng Cheng, Jie Wang, Jianqi Lian, Wenping Gong
64 [GO] 2023―Jan―11 A Perspective on SARS-CoV-2 Virus-like particles Vaccines Xiaoyang Gao, Yeting Xia, Xiaofang Liu, Yinlan Xu, Pengyang Lu, Zhipeng dong, et al. (+2)
65 [GO] 2022―Dec―26 Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19) Woo Sik Kim, Seong-Hun Jeong, Ki-Won Shin, Hyeon Jin Lee, Ji-Young Park, In-Chul Lee, et al. (+4)
66 [GO] 2022―Dec―21 Efficacy and Safety of Tocilizumab, Plasmapheresis and Their Combination in Severe COVID-19: A Randomized Clinical Trial Mohsen Gholinataj jelodar, Shahab Rafieian, Fatemeh Saghafi, Navid Hadad zedegan, Behnaz Birjandi, Shiva Rafieian, et al. (+11)
67 [GO] 2022―Dec―13 Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes Weifeng Shang, Bo Zhang, Yali Ren, Weina Wang, Dengfeng Zhou, Yuanyuan Li
68 [GO] 2022―Dec―09 Effect of inactivated COVID-19 vaccination on pregnancy outcomes following frozen-thawed embryo transfer: a retrospective cohort study Jialyu Huang, Yiqi Liu, Han Zeng, Lifeng Tian, Yina Hu, Jinxia He, et al. (+11)
69 [GO] 2022―Nov―30 The impacts of vaccination status and host factors during early infection on SARS-CoV-2 persistence: a retrospective single-center cohort study Xiangxiang Tian, Yifan Zhang, Wanhai Wang, Fang Fang, Wenhong Zhang, Zhaoqin Zhu, Yanmin Wan
70 [GO] 2022―Nov―18 Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127] Mehmet Tahir Huyut, Zübeyir Huyut
71 [GO] 2022―Nov―09 Low-Dose Naltrexone Reduced Anxiety in Persons with Multiple Sclerosis during the COVID-19 Pandemic Patricia J. McLaughlin, Laura K. Odom, Peter A. Arnett, Shannon Orehek, Gary A. Thomas, Ian S. Zagon
72 [GO] 2022―Nov―07 Role of SARS-CoV-2-induced Cytokine Storm in Multi-Organ Failure: Molecular Pathways and Potential Therapeutic Options Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyed Mahmoud Hashemi
73 [GO] 2022―Oct―14 Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table Mitra Ranjbar, Ali Rahimi, Zeinab Baghernejadan, Atousa Ghorbani, Hossein Khorramdelazad
74 [GO] 2022―Sep―28 Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19 Yipeng Ma, Fenglan Liu, Bin Li, Kaiqi Peng, Hong Zhou, You Xu, et al. (+5)
75 [GO] 2022―Sep―28 Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction Meliana Eka Saputri, Siti Aisyah Rahmalia Effendi, Rifa Nadila, Syauqi Azzam Fajar, Retno Damajanti Soejoedono, Ekowati Handharyani, Okti Nadia Poetri
76 [GO] 2022―Sep―27 The function of myeloid-derived suppressor cells in COVID-19 lymphopenia Taosan Li, Fang Zheng, Fanjun Cheng
77 [GO] 2022―Sep―06 Bioinformatics Pipeline of Indian SARS-CoV-2 Genomes showing Genetic Variability to Synthetic Vaccine Design Nimisha Ghosh, Indrajit Saha, Nikhil Sharma, Suman Nandi
78 [GO] 2022―Aug―22 Molecular Mimicry, Hyperactive Immune System, And SARS-COV-2 Are Three Prerequisites of the Autoimmune Disease Triangle Following COVID-19 Infection Maedeh Vahabi, Tooba Ghazanfari, Saeed Sepehrnia
79 [GO] 2022―Aug―22 Interferon inducible porcine 2′, 5′-oligoadenylate synthetase like-1 protein limits porcine reproductive and respiratory syndrome virus 2 infection via the MDA5-mediated interferon-signaling pathway Mengmeng Zhao, Huiyang Sha, Huawei Li, Hang Zhang, Liangzong Huang, Ruining Wang
80 [GO] 2022―Aug―18 Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine Moein Shirzad, Marjan Nourigorji, Atefe Sajedi, Maryam Ranjbar, Faeze Rasti, Zahra Sourani, et al. (+3)
81 [GO] 2022―Aug―17 Recent advances in the vaccine development for the prophylaxis of SARS Covid-19 Vipul Kumar, Sahil Kumar, Prabodh Chander Sharma
82 [GO] 2022―Aug―08 IL-6 drives T cell death to participate in lymphopenia in COVID-19 Xiaoqi Zhou, Guangming Ye, Yibing Lv, Yanyan Guo, Xingfei Pan, Yirong Li, et al. (+3)
83 [GO] 2022―Aug―08 Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination Mahda Delshad, Mohammad-Javad Sanaei, Atieh Pourbagheri-Sigaroodi, Davood Bashash
84 [GO] 2022―Jul―27 Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates Ying Wang, Yuqing Hao, Mengke Hu, Yadong Wang, Haiyan Yang
85 [GO] 2022―Jul―20 Current evidence on the use of anakinra in COVID-19 Elnaz Khani, Marzieh Shahrabi, Haleh Rezaei, Fariba Pourkarim, Hoda Afsharirad, Mohammad Solduzian
86 [GO] 2022―Jul―12 A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, Seyed Aria Nejadghaderi, Davood Bashash
87 [GO] 2022―Jul―11 Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani
88 [GO] 2022―Jul―06 The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: A longitudinal cohort study Hongbo Chi, Kai Zhou, Liping Shen, Jiaqin Xu, Jun Li, Shiyong Chen, et al. (+4)
89 [GO] 2022―Jul―04 Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis David Setyo Budi, Ihsan Fahmi Rofananda, Nando Reza Pratama, Henry Sutanto, Arisvia Sukma Hariftyani, Saskia Ratna Desita, et al. (+4)
90 [GO] 2022―Jun―28 Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases Ying-Shuang Li, Hua-Cheng Ren, Jian-Hua Cao
91 [GO] 2022―Jun―13 Non-neutralizing antibodies: deleterious or propitious during SARS-CoV-2 infection? Isabella Zanella, Melania Degli Antoni, Valentina Marchese, Francesco Castelli, Eugenia Quiros-Roldan
92 [GO] 2022―Jun―09 Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients Sema Ketenci, M. Uygar Kalaycı, Bağnu Dündar, Recep Duranay, A. Şükrü Aynacıoğlu
93 [GO] 2022―Jun―06 Conjugation with 8-arm PEG and CRM197 enhances the immunogenicity of SARS-CoV-2 ORF8 protein Xiaozhao Tang, Weili Yu, Lijuan Shen, Jinming Qi, Tao Hu
94 [GO] 2022―May―30 Adverse Events Following COVID-19 Vaccination: A Systematic Review and Meta-analysis Hamidreza Kouhpayeh, Hossein Ansari
95 [GO] 2022―May―17 Hematological abnormalities in immunosuppressed patients with COVID-19: evidence from a single center. A cross sectional study Annesi Giacaman, Wolfrang Henriquez, Guillermo Tolosa, Aurora Prado, Roxana Jerez, Yenny Reveco, et al. (+6)
96 [GO] 2022―May―17 BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents Wenping Gong, Yingqing Mao, Yuexi Li, Yong Qi
97 [GO] 2022―Apr―21 Recent Advances in Passive Immunotherapies for COVID-19: The Evidence-Based Approaches and Clinical Trials Pooya Farhangnia, Shiva Dehrouyeh, Amir Reza Safdarian, Soheila Vasheghani Farahani, Melika Gorgani, Nima Rezaei, et al. (+2)
98 [GO] 2022―Apr―19 Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19 Awatef Ben Jemaa, Noura Salhi, Meriam Ben Othmen, Hana Ben Ali, Jihene Guissouma, Hatem Ghadhoune, et al. (+2)
99 [GO] 2022―Apr―18 Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing Pingsen Zhao, Jiahua Zou, Fan Zhou, Yanyan Zhu, Qibin Song, Dongdong Yu, Xiangpan Li
100 [GO] 2022―Apr―14 Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: results from the Vax-On-Profile study Fabrizio Nelli, Agnese Fabbri, Valentina Panichi, Diana Giannarelli, Giuseppe Topini, Julio R. Giron Berrios, et al. (+9)
101 [GO] 2022―Apr―07 Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, Govindasamy Agoramoorthy, Chiranjib Chakraborty
102 [GO] 2022―Mar―18 PREDICTORS OF POOR OUTCOME IN TOCILIZUMAB TREATED PATIENTS WITH SARS-CoV-2 RELATED SEVERE RESPIRATORY FAILURE: A MULTICENTRE REAL WORLD STUDY Luca Masotti, Giancarlo Landini, Grazia Panigada, Elisa Grifoni, Roberto Tarquini, Francesco Cei, et al. (+30)
103 [GO] 2022―Mar―17 Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19 Ladan Abbasian, Negar Toroghi, Hamid Rahmani, Hossein Khalili, Malihe Hasannezhad, Fereshteh Ghiasvand, et al. (+7)
104 [GO] 2022―Mar―15 Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection Pedro R T Romão, Paula C Teixeira, Lucas Schipper, Igor da Silva, Paulo Santana Filho, Luiz Carlos Rodrigues Júnior, et al. (+12)
105 [GO] 2022―Feb―25 COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches Mahdi Zavvar, Aisan Yahyapoor, Sina Zargaran, Hamed Baghdadi, Sara Assadiasl, Kamal Abdolmohammadi, et al. (+9)
106 [GO] 2022―Feb―09 Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study Ritesh Aggarwal, Arun Dewan, Ankita Pandey, Nikita Trehan, Muhammad Aamir Majid
107 [GO] 2022―Feb―04 Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score-matched retrospective cohort study Shinwon Lee, Soon Ok Lee, Jeong Eun Lee, Kye-Hyung Kim, Sun Hee Lee, Soyoon Hwang, et al. (+6)
108 [GO] 2022―Jan―29 A Review on Evolution of Emerging SARS-CoV-2 Variants based on Spike Glycoprotein Nimisha Ghosh, Suman Nandi, Indrajit Saha
109 [GO] 2022―Jan―17 What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? Mehmet Tahir Huyut, Zübeyir Huyut, Fatih İlkbahar, Cuma Mertoğlu
110 [GO] 2022―Jan―11 An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19) Reza Elahi, Parsa Karami, Amir Hossein Heidary, Abdolreza Esmaeilzadeh
111 [GO] 2022―Jan―10 Immunoediting in SARS-CoV-2: Mutual Relationship between the Virus and the Host Nasim Kheshtchin, Parisa Bakhshi, Samaneh Arab, Maryam Nourizadeh
112 [GO] 2022―Jan―06 Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hany Akeel Al-hussaniy, Nasser A. Hadi Al-Harcan, Athanasios Alexiou, Gaber El-Saber Batiha
113 [GO] 2022―Jan―05 Oxidative stress and inflammatory markers in patients with COVID-19: potential role of RAGE, HMGB-1, GFAP and COX-2 in disease severity Fabiolla Rocha Santos Passos, Luana Heimfarth, Brenda Souza Monteiro, Cristiane Bani Corrêa, Tatiana Rodrigues de Moura, Adriano Antunes de Souza Araújo, et al. (+3)
114 [GO] 2021―Dec―21 Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: the IgA and IgG titers increased earlier than the IgM titers Makoto Kurano, Yoshifumi Morita, Yuki Nakano, Rin Yokoyama, Takuya Shimura, Chungen Qian, et al. (+19)
115 [GO] 2021―Dec―15 Levocetirizine and Montelukast in the COVID-19 Treatment Paradigm Bruce Chandler May, Kathleen Holly Gallivan
116 [GO] 2021―Dec―13 Future of antivirals in COVID-19: the case of favipiravir Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
117 [GO] 2021―Dec―10 Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia Luca Masotti, Elisa Grifoni, Giulia Pelagalli, Elisa Cioni, Chiara Mattaliano, Elisa Cioffi, et al. (+14)
118 [GO] 2021―Dec―03 E484K and N501Y SARS-CoV 2 Spike Mutants Increase ACE2 Recognition but Reduce Affinity for Neutralizing Antibody Sandipan Chakraborty
119 [GO] 2021―Nov―27 Antibody response to COVID-19 vaccine: a point of view that can help to optimize dose distribution Massimo Pieri, Eleonora Nicolai, Marco Ciotti, Marzia Nuccetelli, Serena Sarubbi, Martina Pelagalli, Sergio Bernardini
120 [GO] 2021―Nov―23 The dynamic changes of cellular immunity among frontline medical workers who supported Wuhan for fighting against the COVID-19 Juanjuan Yang, Qian Wang, Shuqun Zhang, Zongfang Li, Wei Jiang
121 [GO] 2021―Nov―22 Impact of asthma on COVID-19 mortality in the United States: Evidence based on a meta-analysis Xueya Han, Jie Xu, Hongjie Hou, Haiyan Yang, Yadong Wang
122 [GO] 2021―Nov―20 Tocilizumab in critically ill COVID-19 patients: An observational study Muhammad Z. Mushtaq, Saad B.Z. Mahmood, Aysha Almas, Syed Ather Wasti, Syed Ahsan Ali
123 [GO] 2021―Nov―18 Inactivated SARS-CoV-2 Vaccines Elicit Immunogenicity and T-cell Responses in People Living with HIV Zhengchao Lv, Qin Li, Zaixiong Feng, Xi Zheng, Haihao Yang, Qianlan Gu, et al. (+9)
124 [GO] 2021―Nov―10 Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in the Birjand, Iran Hamed Zare, Hadis Rezapour, Sara Mahmoodzadeh, Mohammad Fereidouni
125 [GO] 2021―Nov―03 COVID-19-Associated Acute Respiratory Distress Syndrome (CARDS): Mechanistic Insights on Therapeutic Intervention and Emerging Trends Komal Thapa, Nitin Verma, Thakur Gurjeet Singh, Amarjot Kaur Grewal, Neha Kanojia, Lata Rani
126 [GO] 2021―Nov―01 Phenylalanine and COVID-19: tracking disease severity markers Rafael Luís Luporini, Henrique Pott-Junior, Maria Carolina B. Di Medeiros Leal, Alex Castro, Antonio Gilberto Ferreira, Marcia Regina Cominetti, Fernanda de Freitas Anibal
127 [GO] 2021―Oct―30 Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic Zakiye Ganjei, Hoorvash Faraji Dana, Sepehr Ebrahimi-Dehkordi, Fereshte Alidoust, Kiumars Bahmani
128 [GO] 2021―Oct―19 SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies Ali Salimi-Jeda, Sina Abbassi, Atieh Mousavizadeh, Maryam Esghaie, Farah Bokharaei-Salim, Farhad Jeddi, et al. (+2)
129 [GO] 2021―Oct―19 Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients Adeleh Sahebnasagh, Seyed Mohammad Nabavi, Hamid Reza Khayat Kashani, Safieh Abdollahian, Solomon Habtemariam, Aysa Rezabakhsh
130 [GO] 2021―Oct―16 The Triumvirate of NF-κB, Inflammation and Cytokine Storm in COVID-19 Ali Attiq, Lui Jin Yao, Sheryar Afzal, Mansoor Ali Khan
131 [GO] 2021―Oct―16 Comparing the Outcomes of Treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 Inpatients Shahram Seyfi, Kayvan Latifi, Parviz Amri male, Mahmoud Sadeghi Haddad Zavareh, Khadijeh Ezoji, Mousa Mohammadnia-Afrozi
132 [GO] 2021―Oct―16 Arthritis following COVID-19 vaccination: a case report Ayşe Ünal Enginar
133 [GO] 2021―Oct―15 Immunopathological events surrounding IL-6 and IFN-α:a bridge for anti-lupus erythematosus drugs used to treat COVID-19 Bangyi Zhou, Siying Li, Jujian Ye, Yi Liu, Longtai Hu, Yan Tang, et al. (+2)
134 [GO] 2021―Oct―12 Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis Yang Liu, Shuo Liu, Yujun Qin, Lei Zhao, Yiliang Li, Chenghui Zhou, Wei Chen
135 [GO] 2021―Oct―08 An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19 Sasan Ghaffari, Hanif Kazerooni, Amir Salehi-Najafabadi
136 [GO] 2021―Oct―08 The oral vaccine based on self-replicating RNA lipid nanoparticles can simultaneously neutralize both SARS-CoV-2 variants alpha and delta Golamabbas Mohammadi, Zahra Sotoudehnia Koranni, Ali Jebali
137 [GO] 2021―Oct―06 Serology-based therapeutic strategy in SARS-CoV-2-infected patients Ricardo Garcia-Muñoz, Giovanna Farfán-Quiroga, Noemí Ruiz-de-Lobera, Jesus Feliu, Judith Anton-Remirez, Maria Jose Nájera Irazu, et al. (+2)
138 [GO] 2021―Oct―04 Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects Antonio Cristiano, Marzia Nuccetelli, Massimo Pieri, Serena Sarubbi, Martina Pelagalli, Graziella Calugi, et al. (+2)
139 [GO] 2021―Oct―04 Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells Wanich Suksatan, Supat Chupradit, Alexei Valerievich Yumashev, Sahithya Ravali, Mohammed Nader Shalaby, Yasser Fakri Mustafa, et al. (+2)
140 [GO] 2021―Sep―28 Monoclonal antibodies for the treatment of COVID-19 patients: an umbrella to overcome the storm? Simone Mornese Pinna, Tommaso Lupia, Silvia Scabini, Davide Vita, Ilaria De Benedetto, Alberto Gaviraghi, et al. (+5)
141 [GO] 2021―Sep―28 In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR Jessica Gasparello, Elisabetta d'Aversa, Giulia Breveglieri, Monica Borgatti, Alessia Finotti, Roberto Gambari
142 [GO] 2021―Sep―24 The Role of Lovastatin in the Attenuation of COVID-19 Sajad Karampoor, Khashayar Hesamizadeh, Zinat Shams, Arefeh Ghafari Novin, Mohammad Farahmand, Hamid Zahednasab, et al. (+8)
143 [GO] 2021―Sep―21 Cytokine storm in the pathophysiology of COVID-19: possible functional disturbances of miRNAs Mona Aslani, Seyed Shahabeddin Mortazavi-Jahromi, Abbas Mirshafiey
144 [GO] 2021―Sep―20 Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: an observational study Gil Verschelden, Maxim Noeparast, Maryam Noparast, Mathijs-Michiel Goossens, Maïlis Lauwers, Frédéric Cotton, et al. (+3)
145 [GO] 2021―Sep―17 A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines Parisa Ghasemiyeh, Soliman Mohammadi-Samani, Negar Firouzabadi, Ali Dehshahri, Afsaneh Vazin
146 [GO] 2021―Sep―15 Rapid diagnosis of COVID-19 in the first year of the pandemic: a systematic review Lysandro Pinto Borges, Aline Fagundes Martins, Breno de Mello Silva, Bruna de Paula Dias, Ricardo Lemes Gonçalves, Daniela Raguer Valadão de Souza, et al. (+7)
147 [GO] 2021―Sep―14 A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19) Sajad Karampoor, Khashayar Hesamizadeh, Faezeh Maleki, Mohammad Farahmand, Hamid Zahednasab, Rasoul Mirzaei, et al. (+8)
148 [GO] 2021―Sep―13 Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue Júlia Leão Batista Simões, Helena Fornari Basso, Greicy Cristine Kosvoski, Jullye Gavioli, Filomena Marafon, Charles Elias Assmann, et al. (+2)
149 [GO] 2021―Sep―09 Forecasting of Oxidant/Antioxidant Levels of COVID-19 Patients by using Expert Models with Biomarkers Used in the Diagnosis/Prognosis of COVID-19 Mehmet Tahir HUYUT, Zübeyir HUYUT
150 [GO] 2021―Sep―09 Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients Paula C. Teixeira, Gilson P. Dorneles, Paulo C. Santana Filho, Igor M. da Silva, Lucas L. Schipper, Isabelle Al Postiga, et al. (+10)
151 [GO] 2021―Sep―09 Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis Lichen Ouyang, Jie Gong, Muqing Yu
152 [GO] 2021―Sep―08 Immune Response Variables and Viral Mutations Impact on COVID-19 Reinfection and Relapse Sarvin Sanaie, Elham Golipour, Ali Shamekh, Mohammad Reza Sadaie, Ata Mahmoodpoor, Mehdi Yousefi
153 [GO] 2021―Sep―03 Effectiveness of corticosteroids to treat severe COVID-19: A systematic review and meta-analysis of prospective studies Han Li, Bingdi Yan, Rong Gao, Jin Ren, Junling Yang
154 [GO] 2021―Aug―30 The who international standard for covid-19 serological tests: towards harmonization of anti-spike assays Maria Infantino, Massimo Pieri, Marzia Nuccetelli, Valentina Grossi, Barbara Lari, Flaminia Tomassetti, et al. (+6)
155 [GO] 2021―Aug―23 Vaccine Design and Delivery Approaches for COVID-19 Kiana Shahzamani, Fatemeh Mahmoudian, Shahrzad Ahangarzadeh, Mohammad Mehdi Ranjbar, Leila Beikmohammadi, Samira Bahrami, et al. (+4)
156 [GO] 2021―Aug―18 Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways Zeinab Amini-Farsani, Mahtab Yadollahi Farsani, Samaneh Arab, Fatemeh Forouzanfar, Mitra Yadollahi, Samira Asgharzade
157 [GO] 2021―Aug―17 Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019 Mina Mohammadhosayni, Fatemeh Sadat Mohammadi, Fatemeh Ezzatifar, Armita Mahdavi Gorabi, Arezou Khosrojerdi, Saeed Aslani, et al. (+7)
158 [GO] 2021―Aug―06 Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries Asim Hussain, Hamza Rafeeq, Hafiza Memoona Asif, Sumaira Shabbir, Muhammad Bilal, Sikandar I. Mulla, et al. (+2)
159 [GO] 2021―Aug―06 Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management Haripriya Sunkara, Syed Masudur Rahman Dewan
160 [GO] 2021―Aug―04 Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial Saghar Barati, Seyed MohammadReza Hashemian, Payam Tabarsi, Atefeh Abedini, Mahshid Ashrafzadeh, Sara Haseli, et al. (+5)
161 [GO] 2021―Aug―03 Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: update, challenges, and perspectives Cassiano Martin Batista, Leonardo Foti
162 [GO] 2021―Jul―31 Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials Ching-Yi Chen, Wang-Chun Chen, Chi-Kuei Hsu, Chien-Ming Chao, Chih-Cheng Lai
163 [GO] 2021―Jul―28 Administration of COVID-19 Vaccines in ImmunocompromisedPatients Manica Negahdaripour, Mojtaba Shafiekhani, Seyed Mohammad Iman Moezzi, Sogand Amiri, Shiva Rasekh, Ashkan Bagheri, et al. (+2)
164 [GO] 2021―Jul―27 Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection Flaminia Tomassetti, Marzia Nuccetelli, Serena Sarubbi, Francesca Gisone, Marco Ciotti, Francesco Spinazzola, et al. (+8)
165 [GO] 2021―Jul―23 Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study Suzan M. Mansour, Rehab N. Shamma, Kawkab A. Ahmed, Nirmeen A. Sabry, Gamal Esmat, Azza A. Mahmoud, Amr Maged
166 [GO] 2021―Jul―23 IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients Payam Tabarsi, Seyed Mohammad Reza Hashemian, Artur Bauhofer, Ali Amir Savadkoohi, Somayeh Ghadimi, Sara Haseli, Farzaneh Dastan
167 [GO] 2021―Jul―21 Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity Mahda Delshad, Ava Safaroghli-Azar, Atieh Pourbagheri-Sigaroodi, Behzad Poopak, Shervin Shokouhi, Davood Bashash
168 [GO] 2021―Jul―15 Corrigendum to “A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial” [Int. Immunopharmacol. 96 (2021) 107743] Alok Sharma, Mili Shah, Satya Lakshmi, Hemangi Sane, Jignasha Captain, Nandini Gokulchandran, et al. (+11)
169 [GO] 2021―Jul―10 Umifenovir in Hospitalized Moderate to Severe COVID-19 Patients: A Randomized Clinical Trial Ilad Alavi Darazam, Shervin Shokouhi, Masoud Mardani, Mohamad Amin Pourhoseingholi, Mohammad Mahdi Rabiei, Firouze Hatami, et al. (+16)
170 [GO] 2021―Jul―10 Autoimmune Phenomena Following SARS-CoV-2 Vaccination Yuval Ishay, Ariel Kenig, Tehila Tsemach-Toren, Radgonde Amer, Limor Rubin, Yoav Hershkovitz, Fadi Kharouf
171 [GO] 2021―Jul―07 Evaluation of Adalimumab Effects in Managing Severe Cases of COVID-19: A Randomized Controlled Trial Atefeh Fakharian, Saghar Barati, Maryam Mirenayat, Mitra Rezaei, Hamidreza Jamaati, Sara Haseli, et al. (+5)
172 [GO] 2021―Jun―29 An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: the COVIFERONII randomized controlled trial Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, Mohamad Amin Pourhoseingholi, Minoosh Shabani, Shervin Shokouhi, et al. (+10)
173 [GO] 2021―Jun―16 Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting Rajesh Naidu Janapal, Jigar Patel, Omar Belfaqeeh, Ali Pourmand
174 [GO] 2021―Jun―16 Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study Ghobad Moradi, Amjad Mohamadi Bolbanabad, Sanaz Ahmadi, Abbas Aghaei, Fares Bahrami, Arshad Veysi, et al. (+5)
175 [GO] 2021―Jun―15 The Risk Factors and Related Hospitalizations for Cases with Positive and Negative COVID-19 Tests: A Case-Control Study Mostafa Ghanei, Hossein Keyvani, Aliakbar Haghdoost, Hassan Abolghasemi, Ghasem Janbabaei, Hamdi Reza Jamshidi, et al. (+4)
176 [GO] 2021―Jun―14 A SINGLE CENTER EXPERIENCE OF INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN COVID-19 Ahmet Omma, Abdulsamet Erden, Berkan Armağan, Serdar Can Güven, Özlem Karakaş, Enes Seyda Şahiner, et al. (+4)
177 [GO] 2021―Jun―14 Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: a historical cohort study Yurie Kobashi, Yoshitaka Nishikawa, Takeshi Kawamura, Tatsuhiko Kodama, Yuzo Shimazu, Daiji Obara, et al. (+2)
178 [GO] 2021―Jun―12 Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial Hossein Kasiri, Nima Rouhani, Ebrahim Salehifar, Monireh Ghazaeian, Sahar Fallah
179 [GO] 2021―Jun―12 CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial Emanuela Sozio, Amato De Monte, Giovanni Sermann, Flavio Bassi, Davide Sacchet, Francesco Sbrana, et al. (+7)
180 [GO] 2021―Jun―02 The Effectiveness of Blood Routine Parameters and Some Biomarkers as a Potential Diagnostic Tool in the Diagnosis and Prognosis of Covid-19 Disease Mehmet Tahir Huyut, Fatih Ilkbahar
181 [GO] 2021―Jun―02 Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5in COVID-19 severity Elías Cuesta-Llavona, Juan Gómez, Guillermo M. Albaiceta, Laura Amado-Rodríguez, Marta García-Clemente, José Gutiérrez-Rodríguez, et al. (+13)
182 [GO] 2021―May―28 Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia Seyed MohammadReza Hashemian, Batoul Khoundabi, Ali Akbar Velayati
183 [GO] 2021―May―24 Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis Durai Sellegounder, Parisa Zafari, Misagh Rajabinejad, Mahdi Taghadosi, Pankaj Kapahi
184 [GO] 2021―May―19 Characteristics of patients with kidney injury associated with COVID-19 Chunjin Ke, Jun Xiao, Zhihua Wang, Chong Yu, Chunguang Yang, Zhiquan Hu
185 [GO] 2021―May―19 The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro Jinglu Lyu, Lirong Bao, Xin Shen, Caixia Yan, Cheng Zhang, Wei Wei, et al. (+6)
186 [GO] 2021―May―11 Insights on the mechanisms of action of ozone in the medical therapy against COVID-19 Salvatore Chirumbolo, Luigi Valdenassi, Vincenzo Simonetti, Dario Bertossi, Giovanni Ricevuti, Marianno Franzini, Sergio Pandolfi
187 [GO] 2021―May―09 Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: a potential COVID-19 treatment Yaoyun Niu, Yang Chen, Pengbo Sun, Yangyang Wang, Jingyi Luo, Yipei Ding, Weidong Xie
188 [GO] 2021―May―06 An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossain pour, Amirhoushang Alvandi, et al. (+2)
189 [GO] 2021―Apr―30 Efficacy of IVIG (Intravenous Immunoglobulin) for Corona Virus Disease 2019 (COVID-19): a meta-analysis Huai-rong Xiang, Xuan Cheng, Yun Li, Wen-wen Luo, Qi-zhi Zhang, Wen-xing Peng
190 [GO] 2021―Apr―30 A Pilot study for treatment of COVID-19 patients in moderate stage using Intravenous administration of Ozonized saline as an adjuvant treatment- Registered Clinical Trial Alok Sharma, Mili Shah, Satya Lakshmi, Hemangi Sane, Jignasha Captain, Nandini Gokulchandran, et al. (+11)
191 [GO] 2021―Apr―28 Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Parisa Zafari, Seyed H. Ghaffari, Davood Bashash
192 [GO] 2021―Apr―27 COVID-19 vaccine hesitancy and related fears and anxiety Antonia Bendau, Jens Plag, Moritz Bruno Petzold, Andreas Ströhle
193 [GO] 2021―Apr―27 Colchicine and Mortality in patients with Coronavirus Disease 2019 (COVID-19) pneumonia: A Systematic Review, Meta-analysis, and Meta-regression Eka Noneng Nawangsih, Yudith Yunia Kusmala, Iis Inayati Rakhmat, Dewi Ratih Handayani, Henny Juliastuti, Arief Wibowo, et al. (+2)
194 [GO] 2021―Apr―21 Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit Yong Du, Zhanjun Lu, Jing Jin, Tianyun Shi, Yi Ding, Ling Qian, et al. (+7)
195 [GO] 2021―Apr―21 Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review Shervin Shokouhi, Saghar Barati, Neda Kazeminia, Faezeh Jamali, Baran Roshan, Zahra Sahraei
196 [GO] 2021―Apr―21 Evaluation of hepatic enzymes activities in COVID-19 patients Rundk Hwaiz, Mohammed Merza, Badraldin Hamad, Shirin HamaSalih, Mustafa Mohammed, Harmand Hama
197 [GO] 2021―Apr―21 Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial Hong Zhao, Chi Zhang, Qi Zhu, Xianxiang Chen, Guilin Chen, Wenjin Sun, et al. (+19)
198 [GO] 2021―Apr―19 A Possible Pathogenic Role of Syndecan-1 in the Pathogenesis of Coronavirus Disease 2019 (COVID-19) Sajad Karampoor, Hamid Zahednasab, Mohammad Farahmand, Rasoul Mirzaei, Farhad Zamani, Alireza Tabibzadeh, et al. (+6)
199 [GO] 2021―Apr―19 Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients Qigao Chen, Baodan Yu, Yihao Yang, Jiewen Huang, Ying Liang, Jing Zhou, et al. (+4)
200 [GO] 2021―Apr―19 The role of vitamin D in reducing SARS-CoV-2 infection: An update Mohammad Shah Alam, Daniel M. Czajkowsky, Md. Aminul Islam, Md. Ataur Rahman
201 [GO] 2021―Apr―16 Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate Platforms Maryam Bayat, Yahya Asemani, Sajad Najafi
202 [GO] 2021―Apr―06 Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting Majid Mokhtari, Minoo Mohraz, Mohammad Mehdi Gouya, Hengameh Namdari Tabar, Katayoun Tayeri, Saeide Aghamohamadi, et al. (+5)
203 [GO] 2021―Apr―06 Acute and Post-Acute Phase of Covid-19: Analyzing Expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and Let-7b-3p in PBMC Tahereh Donyavi, Farah Bokharaei-Salim, Hossein Bannazadeh Baghi, Khadijeh Khanaliha, Mahrokh Alaei Janat-Makan, Bahareh Karimi, et al. (+6)
204 [GO] 2021―Apr―02 Immunopharmacological Perspective on Zinc in SARS-CoV-2 Infection Sima Heydarzadeh Asl, Sepideh Nikfarjam, Naime Majidi Zolbanin, Reza Nassiri, Reza Jafari
205 [GO] 2021―Apr―02 Individual risk management strategy for SARS-CoV2 infection: a step toward personalized healthcare Torsak Tippairote, Massimiliano Peana, Salvatore Chirumbolo, Geir Bjørklund
206 [GO] 2021―Mar―29 Potential SARS-CoV-2 Vaccines: Concept, Progress, and Challenges Seyede Atefe Hosseini, Fatemeh Zahedipour, Hamed Mirzaei, Reza Kazemi Oskuee
207 [GO] 2021―Mar―27 Identification of COVID-19 Subtypes Based on Immunogenomic Profiling Zuobing Chen, Qiushi Feng, Tianfang Zhang, Xiaosheng Wang
208 [GO] 2021―Mar―24 The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials Wei-Ting Lin, Shun-Hsing Hung, Chih-Cheng Lai, Cheng-Yi Wang, Chao-Hsien Chen
209 [GO] 2021―Mar―23 ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19 Mohsen Ahmadi, Salar Pashangzadeh, Pegah Mousavi, Negin Saffarzadeh, Mohammad Amin Habibi, Fatemeh Hajiesmaeili, Nima Rezaei
210 [GO] 2021―Mar―19 The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19 Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri-Sigaroodi, Ava Safaroghli-azar, Nader Bagheri, Davood Bashash
211 [GO] 2021―Mar―14 The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19 Boyi Yang, Xiaoyan Chang, Jiabao Huang, Wen Pan, Zhilong Si, Cuntai Zhang, Hong Li
212 [GO] 2021―Mar―14 Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge Lu-Xiao Hong, Lian Liu, Aifen Lin, Wei-Hua Yan
213 [GO] 2021―Mar―14 The Potential for Lactoferrin to Reduce SARS-CoV-2 Induced Cytokine Storm Michał Zimecki, Jeffrey K. Actor, Marian L. Kruzel
214 [GO] 2021―Mar―12 Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia Masoud Solaymani-Dodaran, Mostafa Ghanei, Mehdi Bagheri, Ali Qazvini, Ensieh Vahedi, Seyed Hassan Saadat, et al. (+38)
215 [GO] 2021―Mar―11 Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues Bingfeng Zheng, Manman Yuan, Qinhai Ma, Shenglan Wang, Yang Tan, Yizhu Xu, et al. (+8)
216 [GO] 2021―Mar―07 The role of probiotics in coronavirus disease-19 infection in Wuhan: A Retrospective study of 311 severe patients Qiang Li, Fang Cheng, Qiling Xu, Yuyong Su, Xuefeng Cai, Fang Zeng, Yu Zhang
217 [GO] 2021―Mar―02 Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis Massimo Pieri, Marco Ciotti, Marzia Nuccetelli, Marco Alfonso Perrone, Maria Teresa Caliò, Maria Stella Lia, et al. (+2)
218 [GO] 2021―Feb―27 Covid-19 Challenges to Immune Investigations and Therapies James E Talmadge, Francois Marceau
219 [GO] 2021―Feb―26 An overview of some potential immunotherapeutic options against COVID-19 Maryam Bayat, Yahya Asemani, Mohammad Reza Mohammadi, Mahsa Sanaei, Mozhdeh Namvarpour, Reyhaneh Eftekhari
220 [GO] 2021―Feb―25 SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis- An Updated Review Eijaz Ahmed Bhat, Johra khan, Nasreena Sajjad, Ahmad Ali, Fahad M. Aldakeel, Ayesha Mateen, et al. (+2)
221 [GO] 2021―Feb―17 Immune response of frontline medical workers providing medical support for Wuhan COVID-19 patients, China Juanjuan Yang, Qian Wang, Shuqun Zhang, Zongfang Li, Wei Jiang
222 [GO] 2021―Jan―29 Immune Response Scenario and Vaccine Development for SARS-CoV-2 Infection Mai H.S. Mohammad
223 [GO] 2021―Jan―28 Interferon-based therapies in COVID-19 Chia Siang Kow, Syed Shahzad Hasan
224 [GO] 2021―Jan―22 COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review Hamed Azhdari Tehrani, Maryam Darnahal, Mohammad Vaezi, Shirin Haghighi
225 [GO] 2021―Jan―22 Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients Yi Zhao, Yujie Liu, Fangzheng Yi, Jun Zhang, Zhaohui Xu, Yehai Liu, Ye Tao
226 [GO] 2021―Jan―22 Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra Esmaeil Mortaz, Ali Bassir, Neda Dalil Roofchayee, Neda K. Dezfuli, Hamidreza Jamaati, Payam Tabarsi, et al. (+7)
227 [GO] 2021―Jan―22 Advances in Immunotherapy for COVID-19: a comprehensive review Masoumeh Masoumi Karimi, Behzad Garmabi, Javad Alizadeh, Erfan Kazemi, Amirhossein Azari Jafari, Mohammad Sadeq Mirmoeini, et al. (+3)
228 [GO] 2021―Jan―12 An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses Golbarg Rahimi, Bahareh Rahimi, Mohammad Panahi, Shadi Abkhiz, Neda Saraygord-Afshari, Morteza Milani, Effat Alizadeh
229 [GO] 2021―Jan―10 Different characteristics of critical COVID-19 and thinking of treatment strategies in non-elderly and elderly severe adult patients Zhelong Liu, Danning Wu, Xia Han, Wangyan Jiang, Lin Qiu, Rui Tang, Xuefeng Yu
230 [GO] 2021―Jan―10 Immunology, Immunopathogenesis and Immunotherapeutics of COVID-19; an Overview Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, Farshid Noorbakhsh
231 [GO] 2020―Dec―30 A review on the effect of COVID-19 in type 2 asthma and its management Srijit Ghosh, Srijita Das, Rupsa Mondal, Salik Abdullah, Shirin Sultana, Sukhbir Singh, et al. (+2)
232 [GO] 2020―Dec―30 The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers Yurie Kobashi, Yuzo Shimazu, Yoshitaka Nishikawa, Takeshi Kawamura, Tatsuhiko Kodama, Daiji Obara, Masaharu Tsubokura
233 [GO] 2020―Dec―28 Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target Nadia Alice Vieira Motta, Lis Jappour Autran, Stephani Correia Brazão, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Gabriel Ferreira Lima, Fernanda Carla Ferreira de Brito
234 [GO] 2020―Dec―26 Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients Parvaneh Baghaei, Farzaneh Dastan, Majid Marjani, Afshin Moniri, Zahra Abtahian, Somayeh Ghadimi, et al. (+11)
235 [GO] 2020―Dec―24 The role of serum specific- SARS-CoV-2 antibody in patients with COVID-19 Hao Chen, Xinyu Zhang, Wanjun Liu, Mingshan Xue, Chenxi Liao, Zhifeng Huang, et al. (+2)
236 [GO] 2020―Dec―23 Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A Phase 1/11 Randomized control Trial (SEOT study) Mili Shah, Jignasha Captain, Vidyadhar Vaidya, Arvind Kulkarni, Kedar Valsalkar, Pradeep M.K. Nair, Gayatri Ganu
237 [GO] 2020―Dec―21 Ozone therapy for the treatment of COVID-19 pneumonia: a scoping review Morteza Izadi, Luca Cegolon, Mohammad Javanbakht, Ali Sarafzadeh, Hassan Abolghasemi, Gholamhossein Alishiri, et al. (+11)
238 [GO] 2020―Dec―17 Genome-wide Analysis of Indian SARS-CoV-2 Genomes to Identify T-cell and B-cell Epitopes from Conserved Regions based on Immunogenicity and Antigenicity Nimisha Ghosh, Nikhil Sharma, Indrajit Saha, Sudipto Saha
239 [GO] 2020―Dec―12 “Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients ” Inanc Karakoyun, Ayfer Colak, Melda Turken, Zeynep Altın, Fatma Demet Arslan, Veli Iyilikci, et al. (+2)
240 [GO] 2020―Dec―09 Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients Yanan Wang, Jingjing Li, Huijun Li, Ping Lei, Guanxin Shen, Chunguang Yang
241 [GO] 2020―Dec―05 Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study Alberto Hernández, Asunción Pablos, Peter J Papadakos, Sergio D. Bergese, Marc Vives
242 [GO] 2020―Dec―05 Convalescent plasma may be a possible treatment for COVID-19: A systematic review Ying Wang, Pengfei Huo, Rulin Dai, Xin Lv, Shaofei Yuan, Yang Zhang, et al. (+4)
243 [GO] 2020―Dec―02 COVID-19 and Cancer: From basic mechanisms to vaccine development using nanotechnology Hyun Jee Han, Chinekwu Nwagwu, Obumneme Anyim, Chinedu Ekweremadu, San Kim
244 [GO] 2020―Dec―02 Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome Abolghasem Allahyari, Mohsen Seddigh-Shamsi, Mahmoud Mahmoudi, Saeid Amel Jamehdar, Mahnaz Amini, Mahnaz Mozdourian, et al. (+17)
245 [GO] 2020―Dec―01 Interferon-inducer antivirals: potential candidates to combat COVID-19 Ashkan Bagheri, Seyed Mohammad Iman Moezzi, Pouria Mosaddeghi, Sadra Nadimi Parashkouhi, Seyed Mostafa Fazel Hoseini, Fatemeh Badakhshan, Manica Negahdaripour
246 [GO] 2020―Nov―30 Neutrophils and COVID-19: The road so far Luiz Henrique Agra Cavalcante-Silva, Deyse Cristina Madruga Carvalho, Éssia de Almeida Lima, José G.F.M. Galvão, Juliane S. de França da Silva, José M. de Sales-Neto, Sandra Rodrigues-Mascarenhas
247 [GO] 2020―Nov―27 The Deregulated Immune Reaction and Cytokines Release Storm (CRS) in COVID-19 disease Ritu Pasrija, Mohammad Naime
248 [GO] 2020―Nov―27 Therapeutic Drugs for SARS-CoV-2 Treatment: Current State and Perspective Bolarin Joshua Adedeji, Oluwatoyosi Mercy Adaramodu, Joshua Iseoluwa Orege, Ayeni Emmanuel Ayodeji, Ibrahim Yusuf Ajibola, Adeyemi Sherif Babatunde, et al. (+6)
249 [GO] 2020―Nov―26 Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: results from an external pilot study Valente Maldonado, Claudia Hernandez-Ramírez, Eniel Alonso Oliva-Pérez, César Omar Sánchez-Martínez, Jorge Fabián Pimentel-González, José Raúl Molina-Sánchez, et al. (+3)
250 [GO] 2020―Nov―20 COVID-19 and Hyperimmune sera: a feasible plan B to fight against coronavirus Camila B P da Costa, Francislene J Martins, Luis E R da Cunha, Norman A. Ratcliffe, Rafael Cisne de Paula, Helena C Castro
251 [GO] 2020―Nov―13 Evaluating the Effects of Intravenous Immunoglobulin (IVIg) on the Management of Severe COVID-19 Cases: A Randomized Controlled Trial Payam Tabarsi, Saghar Barati, Hamidreza Jamaati, Sara haseli, Majid Marjani, Afshin Moniri, et al. (+8)
252 [GO] 2020―Nov―13 The emerging role of microRNAs in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection Rasoul Mirzaei, Farzad Mahdavi, Fariba Badrzadeh, Seyed Reza Hosseini-Fard, Maryam Heidary, Ali Salimi Jeda, et al. (+7)
253 [GO] 2020―Nov―10 Epicardial Adipose Tissue, Inflammatory Biomarkers and COVID-19: Is There a Possible Relationship? Alireza Abrishami, Vahid Eslami, Zahra Baharvand, Nastaran Khalili, Somayeh Saghamanesh, Ehsan Zarei, Morteza Sanei-Taheri
254 [GO] 2020―Nov―03 Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19 Chengyin Liu, Ying Wen, Weiguo Wan, Jingchao Lei, Xuejun Jiang
255 [GO] 2020―Nov―03 Associations of Medications Used during Hospitalization and Immunological Changes in Patients with COVID-19 During 3-Month Follow-up Chao Liu, Yaoshan Dun, Ping Liu, Baiyang You, Kongliang Shu, Huijun Luo, et al. (+4)
256 [GO] 2020―Nov―03 Potential role of interferons in treating COVID-19 patients Mohadeseh Haji Abdolvahab, Shima Moradi-kalbolandi, Mohammad Zarei, Deepanwita Bose, Keivan Majidzadeh-A, Leila Farahmand
257 [GO] 2020―Nov―03 Acute kidney injury and renal replacement therapy in COVID-19 patients: a systematic review and meta-analysis Xiaopeng Yang, Shasha Tian, Hui Guo
258 [GO] 2020―Nov―03 Exploring the Multifocal Therapeutic Approaches in COVID-19: A Ray of Hope Arun Kumar, Asmita Deka Dey, Tapan Behl, Swati Chadha, Vishal Aggarwal
259 [GO] 2020―Nov―03 Chicken Egg Yolk Antibodies (IgYs) block the binding of Multiple SARS-CoV-2 Spike protein variants to human ACE2 Shuangshi Wei, Shengbao Duan, Xiaomei Liu, Hongmei Wang, Shaohua Ding, Yezhou Chen, et al. (+8)
260 [GO] 2020―Oct―31 Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19 Qi Xia, Kaijin Xu, Liang Yu, Huafen Zhang, Lanjuan Li
261 [GO] 2020―Oct―31 The effect of Thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study Qin Sun, Jianfeng Xie, Ruiqiang Zheng, Xuyan Li, Hui Chen, Zhaohui Tong, et al. (+3)
262 [GO] 2020―Oct―20 Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients Hamed Valizadeh, Samaneh Abdolmohammadi-vahid, Svetlana Danshina, Mehmet Ziya Gencer, Ali Ammari, Armin Sadeghi, et al. (+6)
263 [GO] 2020―Oct―13 Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial Reza Malekzadeh, Atefeh Abedini, Behzad Mohsenpour, Ehsan Sharifipour, Roya Ghasemian, Seyed Ali Javad-Mousavi, et al. (+13)
264 [GO] 2020―Oct―12 Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19) Yong Lu, Yongyan Li, Yiping Wang, Jianping Luo, Wanjun Yu
265 [GO] 2020―Oct―10 Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics Negin Ebrahimi, Saeed Aslani, Farhad Babaie, Maryam Hemmatzadeh, Ramin Hosseinzadeh, Zeinab Joneidi, et al. (+3)
266 [GO] 2020―Oct―05 Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study Shilin Fang, Haizhou Wang, Li Lu, Yifan Jia, Zhongyuan Xia
267 [GO] 2020―Oct―03 Novel Serological Biomarkers for Inflammation in Predicting Disease Severity in Patients with COVID-19 Guohui Xue, Xing Gan, Zhiqiang Wu, Dan Xie, Yan Xiong, Lin Hua, et al. (+4)
268 [GO] 2020―Sep―29 The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies Soheila Molaei, Masoomeh Dadkhah, Vahid Asghariazar, Chiman Karami, Elham Safarzadeh
269 [GO] 2020―Sep―25 Continuous tracking of COVID-19 patients' immune status Jingjing Guan, Xin Wei, Shuang Qin, Xiaoyuan Liu, Yujie Jiang, Yingxiao Chen, et al. (+5)
270 [GO] 2020―Sep―23 Risk Factors for Prolonged Viral Clearance in Adult Patients with COVID-19 in Beijing, China: A Prospective Observational Study Jian Xue, Jing Zheng, Xueyi Shang, Enqiang Qin, Peng Zhao, Yuan He, et al. (+4)
271 [GO] 2020―Sep―18 Gender-Associated Difference following COVID-19 virus infection: Implications for Thymosin alpha-1 Therapy Xin Li, Lancong Liu, Yi Yang, Xuefeng Yang, Cengceng Wang, Yan Li, et al. (+6)
272 [GO] 2020―Sep―16 Tocilizumab for treatment patients with COVID-19: recommended medication for novel disease Hamidreza Samaee, Monireh Mohsenzadegan, Shahram Ala, Shahnam Sedigh Maroufi, Parisa Moradimajd
273 [GO] 2020―Sep―14 Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: an observational study Sunali Padhi, Subham Suvankar, Venketesh K. Panda, Abhijit Pati, Aditya K Panda
274 [GO] 2020―Sep―11 Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D Morry Silberstein
275 [GO] 2020―Sep―09 Clinical and laboratory features of COVID-19: Predictors of severe prognosis Aliye Bastug, Hurrem Bodur, Serpil Erdogan, Derya Gokcinar, Sumeyye Kazancioglu, Behiye Deniz Kosovali, et al. (+6)
276 [GO] 2020―Sep―08 Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics V. Kumar
277 [GO] 2020―Aug―31 Drug repurposing and cytokine management in response to COVID-19: a review Luana Heimfarth, Mairim Russo Serafini, Paulo Ricardo Saquete Martins-Filho, Jullyana Souza Siqueira Quintans, Lucindo José Quintans Júnior
278 [GO] 2020―Aug―29 Immunomodulatory-Based Therapy as a Potential Promising Treatment Strategy against Severe COVID-19 Patients: A Systematic Review Mahdieh Razmi, Farideh Hashemi, Elmira Gheytanchi, Masoumeh Dehghan, Roya Ghods, Zahra Madjd
279 [GO] 2020―Aug―28 Outcome of COVID-19 Patients with Use of Tocilizumab: a single center experience Muhammad Zain Mushtaq, Saad Bin Zafar Mahmood, Bushra Jamil, Adil Aziz, Syed A. Ali
280 [GO] 2020―Aug―24 Interferon β-1b in treatment of severe COVID-19: a randomized clinical trial Hamid Rahmani, Effat Davoudi-Monfared, Anahid Nourian, Hossein Khalili, Nooshin Hajizadeh, Narjes zarei Jalalabadi, et al. (+3)
281 [GO] 2020―Aug―24 Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine Rasoul Mirzaei, Rokhsareh Mohammadzadeh, Farzad Mahdavi, Fariba Badrzadeh, Sheida Kazemi, Mehdi Ebrahimi, et al. (+7)
282 [GO] 2020―Aug―21 Immunotherapeutic approaches to curtail COVID-19 Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani
283 [GO] 2020―Aug―19 Association between NLR and COVID-19 Serdar Kalemci, Aydın Sarıhan, Arife Zeybek
284 [GO] 2020―Aug―08 Coronavirus Disease 2019 (COVID-19): Immunological Approaches and Emerging Pharmacologic Treatments Pedram Goodarzi, Farzad Mahdavi, Rasoul Mirzaei, Hamze Hasanvand, Mohammad Sholeh, Farhad Zamani, et al. (+6)
285 [GO] 2020―Aug―08 Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported Marianno Franzini, Luigi Valdenassi, Giovanni Ricevuti, Salvatore Chirumbolo, Markus Depfenhart, Dario Bertossi, Umberto Tirelli
286 [GO] 2020―Aug―06 Thymosin α1 Therapy in Critically Ill Patients with COVID-19: a Multicenter Retrospective Cohort Study Ming Wu, Jing-jing Ji, Li Zhong, Zi-yun Shao, Qi-feng Xie, Zhe-ying Liu, et al. (+5)
287 [GO] 2020―Aug―04 Promising Effects of Tocilizumab in COVID-19: A Non-Controlled, Prospective Clinical Trial Farzaneh Dastan, Ali Saffaei, Sara Haseli, Majid Marjani, Afshin Moniri, Zahra Abtahian, et al. (+16)
288 [GO] 2020―Jul―30 Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing Jin Zhang, Xiaoming Zhang, Jianhua Liu, Yuan Ban, Na Li, Yunhai Wu, et al. (+7)
289 [GO] 2020―Jul―01 Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19 Xiuhong Zhang, Yan Zhang, Weizhen Qiao, Ji Zhang, Zhigang Qi
290 [GO] 2020―Jun―28 Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A Systematic Review Zahra Noorimotlagh, Chiman Karami, Seyyed Abbas Mirzaee, Mohammadreza Kaffashian, Sanaz Mami, Mahdieh Azizi
291 [GO] 2020―Jun―26 Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis Rui Liu, Xinghui Liu, Li Yuan, Huan Han, Muhammad Adnan Shereen, Jiesheng Zhen, et al. (+6)
292 [GO] 2020―Jun―25 Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for Human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis Chengjun Yu, Lian Kang, Jiadong Chen, Na Zang
293 [GO] 2020―Jun―24 Cold-inducible RNA-binding protein (CIRBP) promotes porcine reproductive and respiratory syndrome virus (PRRSV)-induced inflammatory response Xiao Xiao, Wentao Zhang, Deping Hua, Lilin Zhang, Wei Meng, Jinhai Huang, Lei Zhang
294 [GO] 2020―Jun―18 Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses Tania Gupta, Shishir K Gupta
295 [GO] 2020―Jun―16 Use of machine learning and artificial intelligence to predict SARS-CoV-2 infection from full blood counts in a population Abhirup Banerjee, Surajit Ray, Bart Vorselaars, Joanne Kitson, Michail Mamalakis, Simonne Weeks, Louise S. Mackenzie
296 [GO] 2020―Jun―07 Subcutaneous administration of Interferon beta-1a for COVID-19: A non-controlled prospective trial Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Majid Marjani, Afshin Moniri, Hamidreza Jamaati, et al. (+6)
297 [GO] 2020―Jun―06 Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19 Haizhou Wang, Yongxi Zhang, Pingzheng Mo, Jing Liu, Hongling Wang, Fan Wang, Qiu Zhao
298 [GO] 2020―May―08 Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids Amene Saghazadeh, Nima Rezaei
299 [GO] 2020―Apr―16 SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment Scavone Cristina, Rafaniello Concetta, Rossi Francesco, Capuano Annalisa
300 [GO] 2020―Apr―13 The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients Ai-Ping Yang, Jian-ping Liu, Wen-qiang Tao, Hui-ming Li
301 [GO] 2020―Apr―02 The possible of immunotherapy for COVID-19: A systematic review Akram AminJafari, Sorayya Ghasemi
 [1] 

301 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.045 sec